The Latest Settlement

This lecture series highlights advocacy and policy experts who provide technical assistance and leadership development for physicians, residents, and medical students interested in conflict-of-interest reform efforts.
This lecture was recorded on November 1, 2012.
Click to listen or download (1:01:20) – Link to Call Notes

The Latest Settlement:
New Opportunities to Correct Misinformation

Featured Speakers:

  • Adriane Fugh-Berman, MD is an Associate Professor in the Department of Pharmacology and Physiology, Department of Family Medicine at Georgetown University Medical Center and Director of PharmedOut.

Dr. Fugh-Berman presents on the pharmaceutical industry strategy of exchanging off-label marketing information by “scientifically trained” personnel instead of sales reps as differentiated in the recent $181 million settlement between Johnson & Johnson and the Department of Justice regarding the promotion of the antipsychotic Risperdal.

  • Wells Wilkinson, J.D., Director of the Prescription Access Litigation (PAL) project and staff attorney with Community Catalyst.

Mr. Wilkinson presents on opportunities industry settlements present to fund independent prescriber education (academic detailing) as an appropriate remedy for illegal ‘off-label’ drug promotion.


This event is offered as part of the Partnership to Advance Conflict-free Medical Education(PACME). This partnership and related materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the
marketing of the prescription drug Neurontin.

The Partnership to Advance Conflict‐free Medical Education (PACME) is a joint project of the National Physicians Alliance,  the American Medical Student AssociationCommunity Catalyst, and the Pew Charitable Trusts designed to create both external and internal pressure for medical schools and academic medical centers to adopt strong new conflict-of-interest policies.

Learn more at